| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 167,8 k € | +24.7% | 134,5 k € | +26.0% | 106,7 k € | -35.2% | 164,8 k € | +51.6% | 108,7 k € | +45.8% | 74,5 k € | -45.5% | 136,7 k € | +39.8% | 97,7 k € | -13.2% | 112,7 k € | +9.6% | 102,8 k € | +5.2% | 97,7 k € | +8.2% | 90,3 k € | +6.6% | 84,7 k € | +16.2% | 72,9 k € | -32.3% | 107,7 k € | -10.2% | 120,0 k € | +167.0% | 44,9 k € | |
| EBITDA | 166,3 k € | +25.0% | 133,0 k € | +26.3% | 105,3 k € | -35.6% | 163,6 k € | +52.1% | 107,6 k € | +45.9% | 73,7 k € | -45.1% | 134,2 k € | +38.5% | 97,0 k € | -13.4% | 111,9 k € | +9.7% | 102,0 k € | +5.1% | 97,0 k € | +8.1% | 89,7 k € | +7.7% | 83,3 k € | +15.7% | 72,0 k € | -32.6% | 106,8 k € | -9.7% | 118,3 k € | +169.3% | 43,9 k € | |
| Operating profit | 166,3 k € | +25.5% | 132,5 k € | +43.0% | 92,6 k € | -38.6% | 150,9 k € | +58.7% | 95,1 k € | +59.1% | 59,8 k € | -50.0% | 119,6 k € | +69.1% | 70,7 k € | -17.7% | 85,9 k € | +25.8% | 68,3 k € | +8.6% | 62,9 k € | +10.5% | 56,9 k € | +9.1% | 52,2 k € | +25.9% | 41,5 k € | -44.7% | 74,9 k € | -13.6% | 86,7 k € | +801.0% | 9,6 k € | |
| Profit/loss | 139,3 k € | +43.7% | 96,9 k € | +57.2% | 61,7 k € | -42.5% | 107,3 k € | +57.5% | 68,1 k € | +61.3% | 42,2 k € | -48.8% | 82,4 k € | +72.9% | 47,6 k € | -13.2% | 54,9 k € | +30.3% | 42,1 k € | +13.6% | 37,1 k € | +6.0% | 35,0 k € | -11.6% | 39,6 k € | +55.5% | 25,5 k € | -45.9% | 47,1 k € | -18.7% | 57,9 k € | +775.0% | 6,6 k € | |
| Equity | 425,5 k € | +29.6% | 328,4 k € | +4.6% | 313,9 k € | +24.4% | 252,2 k € | +31.3% | 192,0 k € | +38.2% | 138,9 k € | -22.5% | 179,3 k € | +85.0% | 96,9 k € | +96.7% | 49,3 k € | -0.0% | 49,3 k € | -19.3% | 61,1 k € | +154.5% | 24,0 k € | -87.3% | 189,0 k € | +26.5% | 149,4 k € | +20.5% | 124,0 k € | +61.2% | 76,9 k € | +304.4% | 19,0 k € | |
| Total assets | 502,7 k € | +12.6% | 446,6 k € | +16.5% | 383,3 k € | +7.3% | 357,2 k € | +47.3% | 242,5 k € | -12.9% | 278,5 k € | +0.3% | 277,8 k € | +77.8% | 156,3 k € | -15.0% | 183,8 k € | -6.3% | 196,2 k € | -28.5% | 274,4 k € | -19.6% | 341,2 k € | +2.5% | 332,9 k € | +18.1% | 282,0 k € | +1.2% | 278,7 k € | -15.8% | 331,0 k € | +27.7% | 259,3 k € | |
| Cash | 358,1 k € | +77.5% | 201,8 k € | +71.0% | 118,0 k € | -58.5% | 284,4 k € | +54.1% | 184,6 k € | -7.5% | 199,6 k € | +2.9% | 194,0 k € | +141.5% | 80,4 k € | -15.3% | 94,9 k € | +11.2% | 85,4 k € | -52.0% | 178,0 k € | -11.3% | 200,6 k € | +391.6% | 40,8 k € | — | — | — | — | |||||
| Debts | 77,2 k € | -34.7% | 118,2 k € | +70.3% | 69,4 k € | -33.9% | 105,0 k € | +107.8% | 50,5 k € | -63.8% | 139,6 k € | +44.0% | 96,9 k € | +67.8% | 57,7 k € | -56.6% | 132,9 k € | -9.5% | 146,9 k € | -31.1% | 213,3 k € | -32.8% | 317,2 k € | +120.5% | 143,9 k € | +8.9% | 132,1 k € | -14.6% | 154,7 k € | -39.1% | 254,1 k € | +5.8% | 240,3 k € | |
Private limited company · Namur · incorporated on 27/06/2008
Private limited company profitable and well capitalised. Cash position rising (+77.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SCHOONVAERE MEDICAL is a Private limited company incorporated in 2008. Its main activity is: Other human health activities. Its registered office is in Namur.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette